Adenosine and TNF-α exert similar inotropic effect on heart cultures, suggesting a cardioprotective mechanism against hypoxia

Life Sciences

Volumn 81, Issue 10, 2007, Pages 803-813

  El Ani, Dalia ^a,b   Zimlichman, Reuven ^b   Mashiach, Yaakov ^a   Shainberg, Asher ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Adenosine; ATP sensitive potassium channels; Deoxyglucose uptake; H9c2 cardiomyocytes; Heart cultures hypoxia; SERCA2a; TNF

Indexed keywords

ADENOSINE; ADENOSINE DERIVATIVE; DEOXYGLUCOSE; DIAZOXIDE; GLIBENCLAMIDE; ISOPRENALINE; LACTATE DEHYDROGENASE; N(6) PHENYLISOPROPYLADENOSINE; RUBIDIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME RELEASE; HEART CELL CULTURE; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HYPOXIA; IMMUNOHISTOCHEMISTRY; INOTROPISM; NONHUMAN; RAT; REOXYGENATION;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; ANTI-ARRHYTHMIA AGENTS; CELL HYPOXIA; CELL LINE; DEOXYGLUCOSE; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; GLYBURIDE; HEART; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NEUROPROTECTIVE AGENTS; RATS; RUBIDIUM RADIOISOTOPES; SARCOPLASMIC RETICULUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548268530     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.030     Document Type: Article

References (60)

1. 1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs. Journal of Pharmacology & Experimental Therapeutics 308 (2004) 846-856
2. Bianchi P., Pimentel D.R., Murphy M.P., Colucci W.S., and Parini A. A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. Federation of American Societies for Experimental Biology Journal 19 (2005) 641-643
3. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
4. Cohen M.V., Baines C.P., and Downey J.M. Ischemic preconditioning: from adenosine receptor of KATP channel. Annual Review of Physiology 62 (2000) 79-109
5. D'Ascia C., Cittadini A., Monti M.G., Riccio G., and Sacca L. Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. European Heart Journal 27 (2006) 201-206
6. Depre C., and Vatner S.F. Cardioprotection in stunned and hibernating myocardium. Heart Failure Reviews 12 (2007) 307-317
7. Diwan A., Dibbs Z., Nemoto S., DeFreitas G., Carabello B.A., Sivasubramanian N., Wilson E.M., Spinale F.G., and Mann D.L. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation 109 (2004) 262-268
8. Donato M., and Gelpi R.J. Adenosine and cardioprotection during reperfusion-an overview. Molecular and Cellular Biochemistry 251 (2003) 153-159
9. Eddy L.J., Goeddel D.V., and Wong G.H. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. Biochemical and Biophysical Research Communications 184 (1992) 1056-1059
10. El-Ani D., Jacobson K.A., and Shainberg A. Characterization of adenosine receptors in intact cultured heart cells. Biochemistry and Pharmacology 48 (1994) 727-735
11. 1 adenosine receptors by electrical stimulation and amiodarone in rat myocardial cells in vitro. Biochemistry and Pharmacology 54 (1997) 583-587
12. El-Ani D., Jacobson K.A., Zimlichman R., Katz A., and Shainberg A. Uptake of glucose analogs reflects the rate of contraction of cultured myocytes. Journal of Basic and Clinical Physiology and Pharmacology 10 (1999) 287-303
13. El-Ani D., and Zimlichman R. TNFalpha stimulated ATP-sensitive potassium channels and attenuated deoxyglucose and Ca uptake of H9c2 cardiomyocytes. Annales of the New York Academy of Sciences 1010 (2003) 716-720
14. El Ani D., Jacobson K.A., and Shainberg A. Characterization of adenosine receptors in intact cultured heart cells. Biochemistry and Pharmacology 48 (1994) 727-735
15. Engel D., Peshock R., Armstong R.C., Sivasubramanian N., and Mann D.L. Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. American Journal of Physiology- Heart and Circulatory Physiology 287 (2004) H1303-H1311
16. Fu C., Cao C.M., Xia Q., Yang J., and Lu Y. Reactive oxygen species and mitochondrial K(ATP)-sensitive channels mediated cardioprotection induced by TNF-alpha during hypoxia and reoxygenation (in Chinese). Sheng Li Xue Bao 55 (2003) 284-289
17. Gan X.T., Cook M.A., Moffat M.P., and Karmazyn M. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts. Journal of Molecular and Cellular Cardiology 30 (1998) 33-41
18. ATP channels and myocardial preconditioning: an update. American Journal of Physiology- Heart and Circulatory Physiology 285 (2003) H921-H930
19. Halili-Rutman I., Hershko C., Link G., Rutman A.J., and Shainberg A. Inhibition of calcium accumulation by the sarcoplasmic reticulum: a putative mechanism for the cardiotoxicity of adriamycin. Biochemistry and Pharmacology 54 (1997) 211-214
20. Honda H.M., Korge P., and Weiss J.N. Mitochondria and ischemia/reperfusion injury. Annales of the New York Academy of Sciences 1047 (2005) 248-258
21. Hutchinson S.A., and Scammells P.J. A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential. Current Pharmaceutical Design 10 (2004) 2021-2039
22. Jacobson K.A., Hoffmann C., Cattabeni F., and Abbracchio M.P. Adenosine-induced cell death: evidence for receptor-mediated signalling. Apoptosis 4 (1999) 197-211
23. Jones W.K., Brown M., Wilhide M., He S., and Ren X. NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?. Cardiovascular Toxicology 5 (2005) 183-202
24. Kaur K., Sharma A.K., and Singal P.K. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. American Journal of Physiology- Heart and Circulatory Physiology 291 (2006) H106-H113
25. Khan S., Salloum F., Das A., Xi L., Vetrovec G.W., and Kukreja R.C. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. Journal of Molecular and Cellular Cardiology 41 (2006) 256-264
26. Kimura H., Shintani-Ishida K., Nakajima M., Liu S., Matsumoto K., and Yoshida K. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia. Life Sciences 78 (2006) 1901-1910
27. Knuefermann P., Vallejo J., and Mann D.L. The role of innate immune responses in the heart in health and disease. Trends in Cardiovascular Medicine 14 (2004) 1-7
28. 2+ transients. FEBS Letters 376 (1995) 24-30
29. Labruto F., Yang J., Vaage J., and Valen G. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic Research of Cardiology 100 (2005) 198-207
30. Lankford A.R., Yang J.N., Rose'Meyer R., French B.A., Matherne G.P., Fredholm B.B., and Yang Z. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. American Journal of Physiology- Heart and Circulatory Physiology 290 (2006) H1469-H1473
31. Lasley R.D., Keith B.J., Kristo G., Yoshimura Y., and Mentzer Jr. R.M. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent. American Journal of Physiology- Heart and Circulatory Physiology 289 (2005) H785-H791
32. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., and Vanden Hoek T.L. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. American Journal of Physiology- Heart and Circulatory Physiology 284 (2003) H299-H308
33. Lecour S., Rochette L., and Opie L. Free radicals trigger TNF alpha-induced cardioprotection. Cardiovascular Research 65 (2005) 239-243
34. Malave H.A., Taylor A.A., Nattama J., Deswal A., and Mann D.L. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 664 (2003)
35. Mangoni M.E., and Barrere-Lemaire S. Adenosine receptors, heart rate, and cardioprotection. Cardiovascular Research 62 (2004) 447-449
36. Meldrum D.R. Tumor necrosis factor in the heart. American Journal of Physiology 274 (1998) R577-R595
37. Minners J., McLeod C.J., and Sack M.N. Mitochondrial plasticity in classical ischemic preconditioning-moving beyond the mitochondrial KATP channel. Cardiovascular Research 59 (2003) 1-6
38. 1 receptor activation. Journal of the American College of Cardiology 35 (2000) 238-245
39. Mubagwa K., and Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovascular Research 52 (2001) 25-39
40. Nelson S.K., Wong G.H., and McCord J.M. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. Journal of Molecular and Cellular Cardiology 27 (1995) 223-229
41. Neumann J., Boknik P., Begrow F., Hanske G., Justus I., Met'us M., Reinke U., Matherne G.P., and Schmitz W. Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors. Cardiovascular Research 60 (2003) 529-537
42. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circulation Research 94 (2004) 420-432
43. Rezkalla S.K., and Kloner R.A. Preconditioning in humans. Heart Failure Reviews 12 (2007) 201-206
44. 3 receptor activation during hypoxia in isolated rat cardiac myocytes. Molecular and Cellular Biochemistry 217 (2001) 143-152
45. Sarzi-Puttini P., Atzeni F., Doria A., Iaccarino L., and Turiel M. Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 14 (2005) 780-784
46. Setsuta K., Seino Y., Ogawa T., Ohtsuka T., Seimiya K., and Takano T. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circulation Journal 68 (2004) 747-750
47. 3 adenosine receptor activation and its suppression by isoproterenol. Experimental Cell Research 257 (2000) 111-126
48. Shneyvays V., Leshem D., Zinman T., Mamedova L.K., Jacobson K.A., and Shainberg A. Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis following mitochondrial respiratory chain injury. American Journal of Physiology - Heart and Circulatory Physiology 2005 (2005) H2792-H2801
49. Shneyvays V., Zinman T., and Shainberg A. Analysis of calcium responses mediated by the A(3) adenosine receptor in cultured newborn rat cardiac myocytes. Cell Calcium 36 (2004) 387-396
50. Stambaugh K., Elliott G.T., Jacobson K.A., and Liang B.T. Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel. Circulation 99 (1999) 3300-3307
51. Sugano M., Hata T., Tsuchida K., Suematsu N., Oyama J., Satoh S., and Makino N. Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats. Molecular and Cellular Biochemistry 266 (2004) 127-132
52. Tanno M., Gorog D.A., Bellahcene M., Cao X., Quinlan R.A., and Marber M.S. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. Journal of Molecular and Cellular Cardiology 35 (2003) 1523-1527
53. Thornton J., Striplin S., Liu G.S., Swafford A., Stanley A.W., Van Winkle D.M., and Downey J.M. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. American Journal of Physiology 259 (1990) H1822-H1825
54. Tikh E.I., Fenton R.A., and Dobson Jr. J.G. Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts. Am.J.Physiol.Heart Circ.Physiol. 290 (2006) H348-H356
55. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., and Mann D.L. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
56. Wakeno-Takahashi M., Otani H., Nakao S., Uchiyama Y., Imamura H., and Shingu K. Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms. Anesthesiology 100 (2004) 515-524
57. Willems L., Ashton K.J., and Headrick J.P. Adenosine-mediated cardioprotection in the aging myocardium. Cardiovascular Research 66 (2005) 245-255
58. Yitzhaki S., Shneyvays V., Jacobson K.A., and Shainberg A. Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochemistry and Pharmacology 69 (2005) 1215-1223
59. Zheng J., Chin A., Duignan I., Won K.H., Hong M.K., and Edelberg J.M. Growth factor-mediated reversal of senescent dysfunction of ischemia-induced cardioprotection. American Journal of Physiology - Heart and Circulatory Physiology 290 (2006) H525-H530
60. Zurgil N., Shafran Y., Afrimzon E., Fixler D., Shainberg A., and Deutsch M. Concomitant real-time monitoring of intracellular reactive oxygen species and mitochondrial membrane potential in individual living promonocytic cells. Journal of Immunological Methods 316 (2006) 27-41